These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 3377372

  • 1. Calcium antagonists and low density lipoprotein receptors.
    Paoletti R, Bernini F, Fumagalli R, Allorio M, Corsini A.
    Ann N Y Acad Sci; 1988; 522():390-8. PubMed ID: 3377372
    [Abstract] [Full Text] [Related]

  • 2. Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2.
    Corsini A, Granata A, Fumagalli R, Paoletti R.
    Pharmacol Res Commun; 1986 Jan; 18(1):1-16. PubMed ID: 3006091
    [Abstract] [Full Text] [Related]

  • 3. Calcium antagonists increase the amount of mRNA for the low-density lipoprotein receptor in skin fibroblasts.
    Eckardt H, Filipovic I.
    Artery; 1991 Jan; 18(4):168-83. PubMed ID: 1651691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A, Salvayre R.
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [Abstract] [Full Text] [Related]

  • 6. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
    Bouscarel B, Ceryak S, Fromm H.
    Biochim Biophys Acta; 1996 Jun 11; 1301(3):230-6. PubMed ID: 8664333
    [Abstract] [Full Text] [Related]

  • 7. Calcium channel blockers stimulate LDL receptor synthesis in human skin fibroblasts.
    Filipovic I, Buddecke E.
    Biochem Biophys Res Commun; 1986 May 14; 136(3):845-50. PubMed ID: 3718500
    [Abstract] [Full Text] [Related]

  • 8. In vitro inhibition of arterial myocyte growth and stimulation of low density lipoprotein metabolism by SIM 6080, a new calcium antagonist.
    Bernini F, Fantoni M, Corsini A, Fumagalli R.
    Pharmacol Res; 1990 May 14; 22(1):27-35. PubMed ID: 2330336
    [Abstract] [Full Text] [Related]

  • 9. Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.
    Napoli C, Chiariello M, Palumbo G, Ambrosio G.
    Cardiovasc Drugs Ther; 1996 Sep 14; 10(4):417-24. PubMed ID: 8924055
    [Abstract] [Full Text] [Related]

  • 10. Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
    Mori S, Ito H, Yamamoto K.
    Tohoku J Exp Med; 1988 Apr 14; 154(4):329-33. PubMed ID: 3188001
    [Abstract] [Full Text] [Related]

  • 11. LDL receptor gene expression in human mesangial cells under the influence of calcium channel blockers.
    Ruan XZ, Varghese Z, Fernando R, Powas SH, Moorhead JF.
    Clin Nephrol; 1999 May 14; 51(5):263-71. PubMed ID: 10363626
    [Abstract] [Full Text] [Related]

  • 12. [Calcium channel blockers inhibit human low-density lipoprotein peroxidation induced by oxygen free radicals in vitro].
    Napoli C, Ambrosio G, Palumbo G, Chiariello P, Chiariello M.
    Cardiologia; 1992 Nov 14; 37(11):801-4. PubMed ID: 1298553
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
    Lupo E, Locher R, Weisser B, Vetter W.
    Biochem Biophys Res Commun; 1994 Sep 30; 203(3):1803-8. PubMed ID: 7945331
    [Abstract] [Full Text] [Related]

  • 16. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.
    Matsunaga A, Inoue T, Koga T, Mori K, Kugi M, Sasaki J, Arakawa K.
    Cardiovasc Drugs Ther; 1997 Dec 30; 11(6):747-50. PubMed ID: 9512869
    [Abstract] [Full Text] [Related]

  • 17. Antiperoxidative actions of calcium antagonists and atherogenesis.
    Henry PD.
    J Cardiovasc Pharmacol; 1991 Dec 30; 18 Suppl 1():S6-10. PubMed ID: 1723459
    [Abstract] [Full Text] [Related]

  • 18. Calcium antagonists and cholesteryl ester metabolism in macrophages.
    Bernini F, Bellosta S, Didoni G, Fumagalli R.
    J Cardiovasc Pharmacol; 1991 Dec 30; 18 Suppl 10():S42-5. PubMed ID: 1725002
    [Abstract] [Full Text] [Related]

  • 19. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987 Dec 30; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 20. Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes.
    Li Q, Tallant A, Cathcart MK.
    J Clin Invest; 1993 Apr 30; 91(4):1499-506. PubMed ID: 8473496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.